New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 22, 2014
06:56 EDTAGNAllergan price target raised to $230 from $202 at BMO Capital
BMO Capital raised its price target for Allergan shares to $230 citing the company's better than expected Q2 results and improved guidance. BMO calls Allergan's cost-cutting program "quite dramatic" and says it should drive upside to earnings. The firm keeps an Outperform rating on the stock.
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 26, 2015
17:34 EDTAGNActavis registration statement for Allergan acquisition declared effective
Subscribe for More Information
January 21, 2015
12:30 EDTAGNGlaxoSmithKline 'admired' by Pfizer CEO, FT reports
Subscribe for More Information
07:22 EDTAGNActavis price target raised to $330 from $280 at Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use